Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2001 Jul;85(1):F13–F17. doi: 10.1136/fn.85.1.F13

Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants

Z Weintraub, M Solovechick, B Reichman, A Rotschild, D Waisman, O Davkin, A Lusky, Y Bental
PMCID: PMC1721274  PMID: 11420315

Abstract

AIM—To examine the relation between grade III-IV periventricular/intraventricular haemorrhage (PVH/IVH) and antenatal exposure to tocolytic treatment in very low birthweight (VLBW) premature infants.
STUDY DESIGN—The study population consisted of 2794 infants from the Israel National VLBW Infant Database, of gestational age 24-32 weeks, who had a cranial ultrasound examination during the first 28 days of life. Infants of mothers with pregnancy induced hypertension or those exposed to more than one tocolytic drug were excluded. Of the 2794 infants, 2013 (72%) had not been exposed to tocolysis and 781 (28%) had been exposed to a single tocolytic agent. To evaluate the effect of tocolysis and confounding variables on grade III-IV PVH/IVH, the χ2 test, univariate analysis, and a logistic regression model were used.
RESULTS—Of the 781 infants (28%) exposed to tocolysis, 341 (12.2%) were exposed to magnesium sulphate, 263 (9.4%) to ritodrine, and 177 (6.3%) to indomethacin. The overall incidence of grade III-IV PVH/IVH was 13.4%. In the multivariate logistic regression analysis, the following factors were related significantly and independently to grade III-IV PVH/IVH: no prenatal steroid treatment, low gestational age, one minute Apgar score 0-3, respiratory distress syndrome, patent ductus arteriosus, mechanical ventilation, and pneumothorax. Infants exposed to ritodrine tocolysis (but not to the other tocolytic drugs) were at significantly lower risk of grade III-IV PVH/IVH after adjustment for other variables (odds ratio = 0.3; 95% confidence interval 0.2 to 0.6).
CONCLUSION—This study suggests that antenatal exposure of VLBW infants to ritodrine tocolysis, in contrast with tocolysis induced by magnesium sulphate or indomethacin, was associated with a lower incidence of grade III-IV PVH/IVH.



Full Text

The Full Text of this article is available as a PDF (139.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergman B., Hedner T. Antepartum administration of terbutaline and the incidence of hyaline membrane disease in preterm infants. Acta Obstet Gynecol Scand. 1978;57(3):217–221. doi: 10.3109/00016347809154885. [DOI] [PubMed] [Google Scholar]
  2. Costeloe K., Hennessy E., Gibson A. T., Marlow N., Wilkinson A. R. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics. 2000 Oct;106(4):659–671. doi: 10.1542/peds.106.4.659. [DOI] [PubMed] [Google Scholar]
  3. Faxelius G., Hägnevik K., Lagercrantz H., Lundell B., Irestedt L. Catecholamine surge and lung function after delivery. Arch Dis Child. 1983 Apr;58(4):262–266. doi: 10.1136/adc.58.4.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Groome L. J., Goldenberg R. L., Cliver S. P., Davis R. O., Copper R. L. Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. The March of Dimes Multicenter Study Group. Am J Obstet Gynecol. 1992 Oct;167(4 Pt 1):873–879. doi: 10.1016/s0002-9378(12)80004-4. [DOI] [PubMed] [Google Scholar]
  5. Hill W. C. Risks and complications of tocolysis. Clin Obstet Gynecol. 1995 Dec;38(4):725–745. doi: 10.1097/00003081-199538040-00008. [DOI] [PubMed] [Google Scholar]
  6. Iannucci T. A., Besinger R. E., Fisher S. G., Gianopoulos J. G., Tomich P. G. Effect of dual tocolysis on the incidence of severe intraventricular hemorrhage among extremely low-birth-weight infants. Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):1043–1046. doi: 10.1016/s0002-9378(96)80050-0. [DOI] [PubMed] [Google Scholar]
  7. Kuban K. C., Leviton A., Pagano M., Fenton T., Strassfeld R., Wolff M. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol. 1992 Jan;7(1):70–76. doi: 10.1177/088307389200700113. [DOI] [PubMed] [Google Scholar]
  8. Laros R. K., Jr, Kitterman J. A., Heilbron D. C., Cowan R. M., Tooley W. H. Outcome of very-low-birth-weight infants exposed to beta-sympathomimetics in utero. Am J Obstet Gynecol. 1991 Jun;164(6 Pt 1):1657–1665. doi: 10.1016/0002-9378(91)91452-3. [DOI] [PubMed] [Google Scholar]
  9. Lawson E. E., Brown E. R., Torday J. S., Madansky D. L., Taeusch H. W., Jr The effect of epinephrine on tracheal fluid flow and surfactant efflux in fetal sheep. Am Rev Respir Dis. 1978 Dec;118(6):1023–1026. doi: 10.1164/arrd.1978.118.6.1023. [DOI] [PubMed] [Google Scholar]
  10. Leviton A., Paneth N., Susser M., Reuss M. L., Allred E. N., Kuban K., Sanocka U., Hegyi T., Hiatt M., Shahrivar F. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. Pediatrics. 1997 Apr;99(4):E2–E2. doi: 10.1542/peds.99.4.e2. [DOI] [PubMed] [Google Scholar]
  11. Marret S., Gressens P., Gadisseux J. F., Evrard P. Prevention by magnesium of excitotoxic neuronal death in the developing brain: an animal model for clinical intervention studies. Dev Med Child Neurol. 1995 Jun;37(6):473–484. doi: 10.1111/j.1469-8749.1995.tb12035.x. [DOI] [PubMed] [Google Scholar]
  12. McCombs J. Update on tocolytic therapy. Ann Pharmacother. 1995 May;29(5):515–522. doi: 10.1177/106002809502900511. [DOI] [PubMed] [Google Scholar]
  13. Mendez-Bauer C., Shekarloo A., Cook V., Freese U. Treatment of acute intrapartum fetal distress by beta 2-sympathomimetics. Am J Obstet Gynecol. 1987 Mar;156(3):638–642. doi: 10.1016/0002-9378(87)90067-6. [DOI] [PubMed] [Google Scholar]
  14. Ment L. R., Duncan C. C., Ehrenkranz R. A., Kleinman C. S., Pitt B. R., Taylor K. J., Scott D. T., Stewart W. B., Gettner P. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. J Pediatr. 1985 Dec;107(6):937–943. doi: 10.1016/s0022-3476(85)80197-9. [DOI] [PubMed] [Google Scholar]
  15. Ment L. R., Oh W., Ehrenkranz R. A., Philip A. G., Duncan C. C., Makuch R. W. Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol. 1995 Mar;172(3):795–800. doi: 10.1016/0002-9378(95)90001-2. [DOI] [PubMed] [Google Scholar]
  16. Ment L. R., Oh W., Ehrenkranz R. A., Phillip A. G., Vohr B., Allan W., Makuch R. W., Taylor K. J., Schneider K. C., Katz K. H. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr. 1994 Jun;124(6):951–955. doi: 10.1016/s0022-3476(05)83191-9. [DOI] [PubMed] [Google Scholar]
  17. Ment L. R., Oh W., Philip A. G., Ehrenkranz R. A., Duncan C. C., Allan W., Taylor K. J., Schneider K., Katz K. H., Makuch R. W. Risk factors for early intraventricular hemorrhage in low birth weight infants. J Pediatr. 1992 Nov;121(5 Pt 1):776–783. doi: 10.1016/s0022-3476(05)81915-8. [DOI] [PubMed] [Google Scholar]
  18. Mickey R. M., Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989 Jan;129(1):125–137. doi: 10.1093/oxfordjournals.aje.a115101. [DOI] [PubMed] [Google Scholar]
  19. Nakai K., Itakura T., Naka Y., Nakakita K., Kamei I., Imai H., Yokote H., Komai N. The distribution of adrenergic receptors in cerebral blood vessels: an autoradiographic study. Brain Res. 1986 Aug 27;381(1):148–152. doi: 10.1016/0006-8993(86)90703-1. [DOI] [PubMed] [Google Scholar]
  20. Norton M. E., Merrill J., Cooper B. A., Kuller J. A., Clyman R. I. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993 Nov 25;329(22):1602–1607. doi: 10.1056/NEJM199311253292202. [DOI] [PubMed] [Google Scholar]
  21. Ozcan T., Turan C., Ekici E., Gökmen O., Doğan M., Kaleli B., Uludağ H., Karayalçin R. Ritodrine tocolysis and neonatal intraventricular-periventricular hemorrhage. Gynecol Obstet Invest. 1995;39(1):60–62. doi: 10.1159/000292378. [DOI] [PubMed] [Google Scholar]
  22. Paneth N. Classifying brain damage in preterm infants. J Pediatr. 1999 May;134(5):527–529. doi: 10.1016/s0022-3476(99)70231-3. [DOI] [PubMed] [Google Scholar]
  23. Papile L. A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978 Apr;92(4):529–534. doi: 10.1016/s0022-3476(78)80282-0. [DOI] [PubMed] [Google Scholar]
  24. Rantonen T., Ekblad U., Grönlund J., Rikalainen H., Välimäki I., Kero P. Influence of maternal magnesium sulphate and ritodrine treatment on the neonate: a study with six-month follow-up. Acta Paediatr. 1999 Oct;88(10):1142–1146. doi: 10.1080/08035259950168234. [DOI] [PubMed] [Google Scholar]
  25. Salafia C. M., Minior V. K., Rosenkrantz T. S., Pezzullo J. C., Popek E. J., Cusick W., Vintzileos A. M. Maternal, placental, and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks' gestation. Am J Perinatol. 1995 Nov;12(6):429–436. doi: 10.1055/s-2007-994514. [DOI] [PubMed] [Google Scholar]
  26. Stigson L., Kjellmer I. Serum levels of magnesium at birth related to complications of immaturity. Acta Paediatr. 1997 Sep;86(9):991–994. doi: 10.1111/j.1651-2227.1997.tb15185.x. [DOI] [PubMed] [Google Scholar]
  27. Usher R., McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr. 1969 Jun;74(6):901–910. doi: 10.1016/s0022-3476(69)80224-6. [DOI] [PubMed] [Google Scholar]
  28. Vohr B., Ment L. R. Intraventricular hemorrhage in the preterm infant. Early Hum Dev. 1996 Jan 5;44(1):1–16. doi: 10.1016/0378-3782(95)01692-9. [DOI] [PubMed] [Google Scholar]
  29. Walters D. V., Olver R. E. The role of catecholamines in lung liquid absorption at birth. Pediatr Res. 1978 Mar;12(3):239–242. doi: 10.1203/00006450-197803000-00017. [DOI] [PubMed] [Google Scholar]
  30. van Bel F., Klautz R. J., Steendijk P., Schipper I. B., Teitel D. F., Baan J. The influence of indomethacin on the autoregulatory ability of the cerebral vascular bed in the newborn lamb. Pediatr Res. 1993 Aug;34(2):178–181. doi: 10.1203/00006450-199308000-00015. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES